Contracts › 75F40125F19010
75F40125F19010: Pharmaceutical Drug Products
Awarded to We Pharma, Inc. by Food and Drug Administration (FDA).
$75Kobligated
$75Kpotential value
13 November 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40125F19010 |
|---|---|
| Vehicle | 75F40120D00032 |
| Awardee | We Pharma, Inc. |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | MD |
| Period of performance | 14 May 2025 to 13 November 2026 |
| Potential end | 13 November 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record